12638 Federal Register / Vol. 80, No. 46 / Tuesday, March 10, 2015 / Notices 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The portions of the meeting devoted 

to the review and evaluation of journals 

for potential indexing by the National 

Library of Medicine will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(9)(B), Title 5 U.S.C., as 

amended. Premature disclosure of the 

titles of the journals as potential titles to 

be indexed by the National Library of 

Medicine, the discussions, and the 

presence of individuals associated with 

these publications could significantly 

frustrate the review and evaluation of 

individual journals. 

Name of Committee: Literature Selection 

Technical Review Committee. 

Date: June 18–19, 2015. 

Open: June 18, 2015, 8:30 a.m. to 10:45 

a.m. 

Agenda: Administrative. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20894. 

Closed: June 18, 2015, 10:45 a.m. to 5 p.m. 

Agenda: To review and evaluate journals 

as potential titles to be indexed by the 

National Library of Medicine. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20894. 

Closed: June 19, 2015, 8:30 a.m. to 2 p.m. 

Agenda: To review and evaluate journals 

as potential titles to be indexed by the 

National Library of Medicine. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20894. 

Contact Person: Joyce Backus, M.S.L.S., 

Associate Director, Division of Library 

Operations, National Library of Medicine, 

8600 Rockville Pike, Building 38, Room 

2W04, Bethesda, MD 20892, 301–496–6921, 

backusj@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: March 4, 2015. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–05447 Filed 3–9–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Omnibus R03 & R21 SEP–11. 

Date: April 3, 2015. 

Time: 7:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Hotel, Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Eun Ah Cho, Ph.D., Chief, 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, 9609 Medical 

Center Drive, Room 7W104, Bethesda, MD 

20892–9750, 240–276–6342, choe@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI Project 

Program Meeting I. 

Date: May 26–27, 2015. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel and 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Wlodek Lopaczynski, MD, 

Ph.D., Scientific Review Officer, Special 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, 9609 

Medical Center Drive, Room 7W608, 

Rockville, MD 20892, 240–276–6458, 

lopacw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project Meeting II. 

Date: June 4–5, 2015. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington DC/Rockville 

Hotel & Executive Meeting Center, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Shakeel Ahmad, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W122, 

Bethesda, MD 20892–8328, 240–276–6349, 

ahmads@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: March 4, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–05457 Filed 3–9–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–15–15GD] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

mstockstill on DSK4VPTVN1PROD with NOTICES